12945 - Brochure Header

The inaugural Biomarkers & Diagnostics for Complex & Rare Diseases Summit will bring together discovery, translational, diagnostic and biomarker leaders for the advancement of precision medicine across neurology, cardiovascular, renal, rare disease, metabolic, dermatology and NASH indications. Uniting the pharmaceutical, biotech, Dx and healthcare industries, this meeting is the go-to platform for advancing the application of biomarkers and diagnostics to enhance precision medicine drug development, treatment decision making and patient outcomes in rare and complex diseases.

Driving case-study and data-led discussion, download your program for full presentation details and access to…

  • Full BM&Dx speaker line up
  • Detailed presentation topics from Eli Lilly & Co, Yumanity Therapeutics, PfizerBlue Cross Blue Shield Association and more
  • Agenda layout and format of presentations, panels and networking activities

To receive your copy, download the brochure below.



Featured Speakers

Franziska Moeckel

Assistant Vice President, Personalized Health

Inova Health System

Kenneth Rhodes

Chief Scientific Officer

Yumanity Therapeutics

Mike Hutton

Chief Scientific Officer & Vice President, Neurodegeneration Research

Eli Lilly & Co.

Naomi Aronson

Executive Director, Clinical Evaluation, Innovation & Policy, Officer of Clinical Affairs

Blue Cross Blue Shield Association

Gabriel Cohn

Vice President & Clinical Development Lead


George Bashirians

Senior Director & Diagnostics Lead


John Dwyer


Global Alzheimer’s Platform Foundation

Michelle Mielke

Professor, Epidemiology & Neurology

Mayo Clinic